Clinical Trial Update: Anisodine Hydrobromide for Patients With Acute Ischemic Stroke Undergoing Endovascular Therapy (HEAL) [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial is evaluating anisodine hydrobromide for patients with acute ischemic stroke undergoing endovascular therapy, and recruitment has not y…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• Anisodine Hydrobromide (anisodine hydrobromide)

Snippet

Sponsor: Capital Medical University | Conditions: Acute Ischemic Stroke | Phase 1 | Status: NOT_YET_RECRUITING